Skip to content
Screener

Elicio Therapeutics, Inc. ELTX Q2 2026 earnings

Reported August 13, 2026 · After market close

EPS-$0.43Beat by $0.11
EPS estimate-$0.54

Next report

Nov 12, 2026 (in a month)
EPS estimate-$0.44

FAQ

When did Elicio Therapeutics, Inc. report Q2 2026 earnings?
Elicio Therapeutics, Inc. (ELTX) reported Q2 2026 earnings on August 13, 2026 after market close.
What were Elicio Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Elicio Therapeutics, Inc. reported eps of $-0.43 for Q2 2026.
Did Elicio Therapeutics, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.54 by $0.11.
How did Elicio Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 34.8% from $-0.66.
Where can I find Elicio Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001601485-26-000055) and the 10-Q periodic report (0001601485-26-000056) directly on SEC EDGAR. The filing index links above go to sec.gov.